|
gptkbp:instanceOf
|
gptkb:drug
antidepressant
norepinephrine reuptake inhibitor
|
|
gptkbp:approvedBy
|
gptkb:FDA
2013
|
|
gptkbp:ATCCode
|
N06AX28
|
|
gptkbp:brand
|
Fetzima
|
|
gptkbp:CASNumber
|
96847-46-8
|
|
gptkbp:chemicalFormula
|
C15H22N2O
|
|
gptkbp:developedBy
|
Pierre Fabre Medicament
|
|
gptkbp:eliminationHalfLife
|
12 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasEnantiomer
|
gptkb:milnacipran
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
levomilnacipran
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
serotonin-norepinephrine reuptake inhibition
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
246.35 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:relatedTo
|
gptkb:milnacipran
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
constipation
increased heart rate
erectile dysfunction
hyperhidrosis
|
|
gptkbp:usedFor
|
gptkb:major_depressive_disorder
|
|
gptkbp:bfsParent
|
gptkb:Serotonin-norepinephrine_reuptake_inhibitors
gptkb:Venlafaxine
gptkb:serotonin-norepinephrine_reuptake_inhibitors
gptkb:SNRIs
|
|
gptkbp:bfsLayer
|
7
|